Biotech Catalysts For The Week Ahead
After a week in which they came under pressure, what does the week ahead have in store for biotech stocks? Today’s article outlines the key…
After a week in which they came under pressure, what does the week ahead have in store for biotech stocks? Today’s article outlines the key…
“Amid a relatively dry IPO year, biotech IPOs have boomed,” notes the author of today’s article, who proceeds to highlight what he believes are two…
If the biotech highlighted in today’s article ends up getting its drug approved, it would be the first Alzheimer’s treatment that actually reduces the cognitive…
There’s a new ETF on the scene with a focus on small-cap biotech companies, offering investors exposure to junior disruptors in the biotech space. For…
“With coronavirus cases climbing in the U.S., this is likely going to be a clear focus for quite some time,” declares the author of today’s…
Shares of the biotech highlighted in today’s article have soared this year, but is this performance due to factors such as the COVID-19 drug the…
“July is a critical month for several leading biotech companies, and there’s a lot that investors need to know if they want to make a…
On the heels of Novavax receiving $1.6 billion in federal aid for its COVID-19 vaccine candidate, the author of today’s article advises that “investors might…
“This pandemic-driven frenzy for drugmaker stocks has made it awfully hard for investors who like to focus on the fundamentals,” notes the author of today’s…
Could a COVID-19 vaccine – or vaccines – be approved before the November election? That’s the bold prediction being made by Jefferies – and if…